0       0

NACCT 2015


MON100b - AAPCC SPI Clinical Symposium:SPI Clinical Practice Symposium: Anti-Do's and Anti-Dont's: The Benefits and Pitfalls of Antidote Administration


Oct 12, 2015 1:00pm ‐ Oct 12, 2015 2:00pm

Standard: $15.00

Description

Sophie Gosslin, MD
Objectives:

  • Describe examples of situations in which each of the antidotes would be considered for use.
  • Describe the clinical scenario in which these same antidotes would be contraindicated.
Elizabeth Scharman, PharmD, DABAT
Objectives:
  • Identify infrequently used antidotes (cyproheptadine, flumazenil and physostigmine) that may be beneficial in treating overdose patients, including indications, side effects, dosages and interactions.
  • Identify the benefits and risks associated with each antidote.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content